Mind Medicine earnings were -$77.6M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest MNMD earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$23.3M, down 32.8% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, MNMD reported annual earnings of -$108.7M, with 13.5% growth.
On MNMD's earnings call on Invalid Date, Mind Medicine (NASDAQ: MNMD) reported Q1 2025 earnings per share (EPS) of -$0.27, up 76.32% year over year. Total MNMD earnings for the quarter were -$23.35 million. In the same quarter last year, Mind Medicine's earnings per share (EPS) was -$1.14.
As of the last Mind Medicine earnings report, Mind Medicine is currently losing money. Mind Medicine's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$77.63 million, a 38.06% decrease year over year.
What was MNMD's earnings growth in the past year?
As of Mind Medicine's earnings date in Invalid Date, Mind Medicine's earnings has grown year over year. MNMD earnings in the past year totalled -$77.63 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.